A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India
Phase of Trial: Phase IV
Latest Information Update: 19 Dec 2016
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms LEAD-IN
- Sponsors Novo Nordisk
- 04 Mar 2013 New source identified and integrated (Clinical Trials Registry - India, CTRI2010-091-001280).
- 10 May 2012 Actual patient number is 1386 according to ClinicalTrials.gov.
- 10 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.